Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01107379 · ClinicalTrials.gov registry record
Optimization and Refinement of Technique in In-Office Sinus Dilation 2
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 203
- Enrollment target
NCT01107379 is a clinical trial that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 203 participants.
The verdict
NCT01107379 has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 203 participants
- Enrollment target
Study Summary
A prospective, multi-arm, multi-center, observational post-market study of balloon sinus dilatation in the physician office setting under local anesthesia to treat patients with chronic rhinosinusitis (CRS). All products intended for use in this study have been FDA cleared for sale in the U.S.A.
Interventions
- DEVICE Relieva Balloon Sinuplasty System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01107379
The ClinicalTrials.gov registry entry for NCT01107379 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relieva Balloon Sinuplasty System is the first listed.
NCT01107379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01107379 about?
NCT01107379 is a clinical study titled "Optimization and Refinement of Technique in In-Office Sinus Dilation 2". A prospective, multi-arm, multi-center, observational post-market study of balloon sinus dilatation in the physician office setting under local anesthesia to treat patients with chronic rhinosinusitis (CRS). All products intended for use in this study have been FDA cleared for sale in the U.S.A.
What is the current status of trial NCT01107379?
This trial is currently completed. The enrollment target is 203 participants. The study started on 2010-04. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01107379?
The interventions under investigation include: Relieva Balloon Sinuplasty System (DEVICE).
Who is sponsoring clinical trial NCT01107379?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.